E

Eupraxia Pharmaceuticals
D

EPRX

4.41000
USD
0.16
(3.76%)
مغلق
حجم التداول
676
الربح لكل سهم
-1
العائد الربحي
-
P/E
-6
حجم السوق
158,095,647
أصول ذات صلة
AMZN
AMZN
-2.920
(-1.37%)
209.610 USD
COST
COST
4.94
(0.51%)
979.60 USD
CVS
CVS
-0.290
(-0.43%)
66.570 USD
DG
DG
-0.740
(-0.66%)
111.540 USD
DLTR
DLTR
1.160
(1.19%)
98.740 USD
KR
KR
6.450
(9.85%)
71.960 USD
TGT
TGT
0.395
(0.42%)
95.545 USD
W
WBA
-0.075
(-0.66%)
11.310 USD
WMT
WMT
0.990
(1.04%)
96.110 USD
المزيد
المقالات

العنوان: Eupraxia Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.